Suchergebnisse - "Hahn, Christopher N"

PubPharm (114)

1

Unravelling Facets of MECOM-Associated Syndrome : Somatic Genetic Rescue, Clonal Hematopoiesis and Phenotype Expansion

enthalten in: Blood advances | 2024

von Venugopal, P. | Arts, P. | Fox, L. | +48

2

The 10th Barossa meeting : Cell Signalling to Cancer Medicine

enthalten in: Cell death & disease | 2024

von Kan, W. | McClure, B. | Hahn, C. | +1

3

IDH Mutant Myeloid Neoplasms are Associated with Seronegative Rheumatoid Arthritis and Innate Immune Activation

enthalten in: Blood | 2024

von Hong, L. | Wechalekar, M. | Kutyna, M. | +21

4

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41

enthalten in: Blood advances | 2023

von Homan, C. | Drazer, M. | Yu, K. | +63

5

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

enthalten in: Blood cancer journal | 2023

von Shah, M. | Tran, E. | Shah, S. | +19

6

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma

enthalten in: Blood | 2023

von Flerlage, J. | Myers, J. | Maciaszek, J. | +26

CommentIn: Blood. 2023 Mar 16;141(11):1240-1241. - PMID 36929435

7

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies

enthalten in: Blood advances | 2023

von Saygin, C. | Roloff, G. | Hahn, C. | +17

8

Novel modes of MPL activation in triple-negative myeloproliferative neoplasms

enthalten in: Pathology | 2023

von Samaraweera, S. | Geukens, T. | Casolari, D. | +17

9

Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy

enthalten in: Frontiers in oncology | 2023

von Zerella, J. | Homan, C. | Arts, P. | +3

10

Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms

enthalten in: Current hematologic malignancy reports | 2022

von Baranwal, A. | Hahn, C. | Shah, M. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]